4D Medicine raises €2.5M Series B round
16 October 2024· Nottingham, United Kingdom· health, biotech, materials, b2b, deep_hardware
The funding will be used to support the company’s expansion into the US market and complete its first-in-human clinical trials.
Investors
LeadMEIF II Birmingham Equity Fund
Also participating
SFC CapitalMercia VenturesDSW Ventures
About 4D Medicine
Stage
Series B
Headquarters
Nottingham, United Kingdom
Founded
2018
Team Size
6–20
Sectors
healthbiotechmaterialsb2bdeep_hardware
Source: https://www.mercia.co.uk/news/4d-medicine-secures-2-2m-from-the-meif-ii-birmingham-equity-fund/